SEAMLESS: Second generation Adoptive cell therapy using MoLEcular growth SwitcheSss
Lead Participant:
CELLULAR THERAPEUTICS LTD
Abstract
Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.
Lead Participant | Project Cost | Grant Offer |
|---|---|---|
| CELLULAR THERAPEUTICS LTD | £419,518 | £ 188,783 |
People |
ORCID iD |
| J Bridgeman (Project Manager) |